NCT04221945 2026-02-20
KEYNOTE-A18
Merck Sharp & Dohme LLC
Phase 3 Completed
Clinical Trials
6 trialsNCT03830866 2024-07-26
CALLA
AstraZeneca
Phase 3 Completed
NCT01851772 2021-01-12
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Xoft, Inc.
Phase NA Completed
NCT01017549 2020-08-13
Post Market Study Using the Xoft Axxent System
Xoft, Inc.
Phase NA Completed
NCT01045187 2012-08-01
Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer
Xoft, Inc.
Phase NA Completed
NCT00191100 2009-08-11
Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix
Eli Lilly and Company
Phase 3 Completed